Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for cardiovascular diseases. – PubMed – NCBI Drug Discov Today. 2016 Jan;21(1):1-4. doi: 10.1016/j.drudis.2014.09.001. Epub 2014 Sep 15. Source: An analysis of FDA-approved drugs for cardiovascular diseases. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 New drug discovery: extraordinary opportunities in an uncertain time. – PubMed – NCBI Drug Discov Today. 2015 Nov;20(11):1288-92. doi: 10.1016/j.drudis.2014.12.008. Epub 2014 Dec 17. Source: New drug discovery: extraordinary opportunities in an uncertain time. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of original research contributions toward FDA-approved drugs. – PubMed – NCBI Drug Discov Today. 2015 Oct;20(10):1182-7. doi: 10.1016/j.drudis.2015.06.006. Epub 2015 Jun 22. Source: An analysis of original research contributions toward FDA-approved drugs. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 A history of drug development in four acts. – PubMed – NCBI Drug Discov Today. 2015 Oct;20(10):1163-8. doi: 10.1016/j.drudis.2015.04.003. Epub 2015 Apr 20. Source: A history of drug development in four acts. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for neurological disorders. – PubMed – NCBI Drug Discov Today. 2015 Sep;20(9):1040-3. doi: 10.1016/j.drudis.2015.02.003. Epub 2015 Feb 11. Source: An analysis of FDA-approved drugs for neurological disorders. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for inflammation and autoimmune diseases. – PubMed – NCBI Drug Discov Today. 2015 Aug;20(8):920-3. doi: 10.1016/j.drudis.2015.02.006. Epub 2015 Feb 17. Source: An analysis of FDA-approved drugs for inflammation and autoimmune diseases. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 Target selection for FDA-approved medicines. – PubMed – NCBI Drug Discov Today. 2015 Jul;20(7):784-9. doi: 10.1016/j.drudis.2014.11.001. Epub 2014 Nov 11. Source: Target selection for FDA-approved medicines. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 2014 in review: FDA approval of new drugs. – PubMed – NCBI Drug Discov Today. 2015 Jun 19. pii: S1359-6446(15)00234-2. doi: 10.1016/j.drudis.2015.06.004. [Epub ahead of print] Source: 2014 in review: FDA approval of new drugs. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for metabolic diseases. – PubMed – NCBI Drug Discov Today. 2015 Jun;20(6):648-51. doi: 10.1016/j.drudis.2015.02.002. Epub 2015 Feb 11. Source: An analysis of FDA-approved drugs for metabolic diseases. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 Sources of innovation: an assessment of intellectual property. – PubMed – NCBI Drug Discov Today. 2015 May;20(5):500-4. doi: 10.1016/j.drudis.2014.12.002. Epub 2014 Dec 9. Source: Sources of innovation: an assessment of intellectual property. – PubMed – NCBI